HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Corinne Le Goff Appointed Viatris Chief Commercial Officer
Corinne Le Goff is an accomplished biotechnology and pharmaceutical executive with more than 25 years of experience leading and building highly successful teams globally.
Julie Blasingim Promoted to Chief Executive Officer of Univo IRB
Julie Blasingim, formerly President, has over 20 years of experience in the clinical research industry.
John Witkowski Appointed President & CEO of Solesis
John Witkowski served as President of DSM Biomedical, the global biomaterials division of dsm-firmenich, where he led a significant period of transformational growth.
Julia James Appointed Clario Chief Legal and Administrative Officer
Julia James served as Executive Vice President and General Counsel of PPD, the leading contract research organization, until its acquisition by Thermo Fisher Scientific in 2021. She then continued as General Counsel, Clinical Research, following the transaction.
John Edwards Appointed PanTher Therapeutics Executive Chair of the Board of Directors
John Edwards brings over 35 years of experience in discovery, development, and global commercialization of biopharmaceuticals to PanTher. His experience includes involvement with ten FDA approved biologics and eight biotech companies with successful exits, including Tilos Therapeutics, Siamab, Adnexus, F-star and Genetics Institute.
Lori Shoaf Joins AAOS as Vice President of the Office of Govenment Relations
Lori Shoaf spent a decade as the executive director of partnerships, advocacy and coalitions at the Blue Cross Blue Shie Association. She also has previous federal government relations experience at several member healthcare associations.
RIVANNA® Welcomes Craig Loomis to Drive Product Excellence
Will Mauldin, PhD, RIVANNA co-founder and CEO on the appointment of Craig Loomis, "Craig's proven track record in driving revenue growth, launching innovative products and cultivating customer relationships will be pivotal in driving the successful adoption of Accuro 3S within the acute pain neuraxial market and its adjacent indications, which collectively represent a total addressable market exceeding $1 billion."
Unveiling a Visionary Leader: Dr A Burton Tripathi Assumes CEO Role at Beyeonics
Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor Appointed Head of Quality & Compliance Practice at ELIQUENT Life Sciences
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
